Clinical Trial Update: Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating safety and efficacy of filgotinib, lanraplenib, and tirabrutinib in adults with active Sjogren's syndrome has completed with posted r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjogren Syndrome

Drugs mentioned

• Filgotinib (filgotinib)
• Tirabrutinib (tirabrutinib)
• lanraplenib (lanraplenib)

Snippet

Sponsor: Gilead Sciences | Conditions: Sjogren's Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2020-01-22